In this regard, upregulation of the latter receptor has been shown to be associated with increased TGF-β-mediated growth inhibition [35], whereas its reduced expression contributes to the loss of sensitivity to TGF-β and the increased proliferation of some cancer cells [36, 37]. Here, TGFB1 is linked to cancer.